ST6GAL1 is a novel serum biomarker for lenvatinib-susceptible FGF19-driven hepatocellular carcinoma
| Image |  |
|---|---|
| Description | scientific article published on 07 December 2020 |
| Author/s |
author: Ryotaro Sakamori Kazuyoshi Ohkawa Hidetoshi Eguchi Satoshi Tanaka |
| Publication date | December 7, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |